Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Neurobiology of Disease

• Publication date

  2002-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/NBDI.2002.0494PMID 12079401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Parkinson's disease. The apoptosis hypothesis revisited.

  2001cited by this paper
• Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects.

  2000cited by this paper
• The biochemistry of apoptosis

  2000cited by this paper
• Disrupted mitochondrial electron transport function increases expression of anti‐apoptotic Bcl‐2 and Bcl‐XL proteins in SH‐SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress

  2000cited by this paper
• Mitochondria as the central control point of apoptosis.

  2000cited by this paper
• Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease

  2000cited by this paper
• Cell death mechanisms in Parkinson's disease

  2000cited by this paper
• Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease

  1999cited by this paper
• Cell death and apoptosis regulating proteins in Parkinson’s disease – a cautionary note

  1999cited by this paper
• Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo.

  1999cited by this paper
• Understanding cell death in parkinson's disease

  1998cited by this paper
• Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity.

  1998cited by this paper
• Bcl-2 Protein as a Marker of Neuronal Immaturity in Postnatal Primate Brain

  1998cited by this paper
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride Neurotoxicity Is Attenuated in Mice Overexpressing Bcl-2

  1998cited by this paper
• Parkinson's disease. Second of two parts.

  1998cited by this paper
• Function and expression of the Bcl-x gene in the developing and adult nervous system

  1995cited by this paper
• bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death.

  1995cited by this paper
• Overexpression of Bcl-2 attenuates MPP+, but not 6-ODHA, induced cell death in a dopaminergic neuronal cell line

  1995cited by this paper
• Ageing and Parkinson's disease: substantia nigra regional selectivity.

  1991cited by this paper
• Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study.

  1990cited by this paper

• Senolytics: opening avenues in drug discovery to find novel therapeutics for Parkinson's disease.

  2023cites this paper
• Demystifying the Neuroprotective Role of Neuropeptides in Parkinson’s Disease: A Newfangled and Eloquent Therapeutic Perspective

  2022cites this paper
• Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease

  2022cites this paper
• Elucidating the Neuroprotective Role of PPARs in Parkinson’s Disease: A Neoteric and Prospective Target

  2021cites this paper
• MCL1 as a Therapeutic Target in Parkinson's Disease?

  2019cites this paper
• Effect of cholestasis and NeuroAid treatment on the expression of Bax, Bcl-2, Pgc-1α and Tfam genes involved in apoptosis and mitochondrial biogenesis in the striatum of male rats

  2019cites this paper
• Nutritional Regulators of Bcl-xL in the Brain

  2018cites this paper
• Gene networks in neurodegenerative disorders.

  2017cites this paper
• Effect of Buspirone, Fluoxetine and 8-OH-DPAT on Striatal Expression of Bax, Caspase-3 and Bcl-2 Proteins in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rats.

  2015cites this paper
• A CHRONIC, PROGRESSIVE NEUROLOGICAL DISORDER PARKINSON'S DISEASE- MECHANISMS AND TREATMENT

  2014cites this paper
• DOCTOR OF PHILOSOPHY IN BIOTECHNOLOGY

  2013cites this paper
• Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype.

  2012cites this paper
• Programmed cell death in Parkinson's disease.

  2012cites this paper
• Protective effects of kidney-tonifying Chinese herbal preparation on substantia nigra neurons in a mouse model of Parkinson's disease

  2012cites this paper
• Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's disease.

  2011cites this paper
• Bone marrow cells differentiation to neurons in the rat brain using Serotonin and GABA:Their role on glutamate receptors, IP3, cAMP and cGMP functional regulation in unilateral Parkinsonism induced by 6-hydroxydopamine

  2011cites this paper
• Apoptosis of peripheral blood lymphocytes in Parkinson patients.

  2010cites this paper
• Apoptosis in Neurodegenerative Diseases

  2009cites this paper
• Enhanced dopaminergic differentiation of human neural stem cells by synergistic effect of Bcl‐xL and reduced oxygen tension

  2009cites this paper
• PPAR: a therapeutic target in Parkinson’s disease

  2008cites this paper
• Differential nigral expression of Bcl-2 protein family in chronically haloperidol and clozapine-treated rats: role in neurotoxicity and stereotyped behavior.

  2007cites this paper
• Membrane‐permeable Bcl‐xL prevents MPTP‐induced dopaminergic neuronal loss in the substantia nigra

  2007cites this paper
• Differential nigral expression of bcl-2 protein family in the pure and common forms of Dementia with Lewy bodies: relevance for dopaminergic neuronal vulnerability

  2007influential citation
• Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide.

  2007cites this paper
• Is Parkinson's disease an autoimmune disorder of endogenous vasoactive neuropeptides?

  2007cites this paper
• Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects.

  2006cites this paper
• TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial.

  2006cites this paper
• Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease.

  2006cites this paper
• Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease.

  2005cites this paper
• Dopamine and Neurodegeneration

  2005cites this paper
• Bcl-x Is Required for Proper Development of the Mouse Substantia Nigra

  2005influential citation
• Overexpression of Superoxide Dismutase or Glutathione Peroxidase Protects against the Paraquat + Maneb-induced Parkinson Disease Phenotype*

  2005cites this paper
• New Therapeutic Approaches to Parkinson’s Disease Including Neural Transplants

  2005cites this paper
• Enhanced In Vitro Midbrain Dopamine Neuron Differentiation, Dopaminergic Function, Neurite Outgrowth, and 1-Methyl-4-Phenylpyridium Resistance in Mouse Embryonic Stem Cells Overexpressing Bcl-XL

  2004cites this paper
• Postmortem studies in Parkinson's disease

  2004cites this paper
• Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment

  2004cites this paper
• Minocycline protects basal forebrain cholinergic neurons from mu p75‐saporin immunotoxic lesioning

  2004cites this paper
• Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson’s disease

  2004cites this paper
• Interactions between the cells of the immune and nervous system: neurotrophins as neuroprotection mediators in CNS injury.

  2004cites this paper
• Apoptosis vs Nonapoptotic Mechanisms in Neurodegeneration

  2003cites this paper
• Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease.

  2003cites this paper
• General aspects of neurodegeneration.

  2003cites this paper
• Apoptosis and Parkinson's disease.

  2003cites this paper
• Parkinson's Disease Mechanisms and Models

  2003cites this paper